Recent Updates
Recently added Catalysts
MXCT Positive Sentiment Score: 70/100

MaxCyte to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025, and Participate in Upcoming Investor Conference

Friday, February 7, 2025 1 min read
Key Takeaway: MaxCyte, Inc. announced it will release its financial results for Q4 and the full year 2024 on March 11, 2025. The company will hold a conference call to discuss these results after the market closes. Additionally, MaxCyte will participate in the 45th Annual TD Cowen Healthcare Conference on March 3, where management will be available for a fireside chat. Investors are encouraged to register for the conference call and will have access to a webcast of the events.

Market Sentiment Analysis

POSITIVE FACTORS

  • MaxCyte is set to provide key financial results for investors, indicating transparency.
  • The participation in the upcoming TD Cowen Healthcare Conference suggests engagement with investors.
  • The company's focus on cell-engineering positions it favorably in the biopharma market.

Full Press Release Details

ROCKVILLE, Md., Feb. 07, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the fourth quarter and full year 2024 after the U.S. market close on Tuesday, March 11th, 2025. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.
Earnings Conference Call Details
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Events” section of the MaxCyte website at https://investors.maxcyte.com/.
Company management will also participate in the following investor conference:
45th Annual TD Cowen Healthcare Conference
Fireside Chat on Monday, March 3rd at 10:30 a.m. ET
A live and archived webcast of the Cowen fireside chat will be available on the “Event” section of the MaxCyte investor relations website at https://investors.maxcyte.com/.
jvines@spectrumscience.com
Nominated Adviser and Joint Corporate Broker
Emma Earl / Freddy Crossley
maxcyte@icrhealthcare.com

Frequently Asked Questions

When will MaxCyte release its financial results for 2024?

MaxCyte will release its financial results on March 11, 2025, after U.S. market close.

What time is the earnings conference call scheduled?

The earnings conference call is set for 4:30 p.m. Eastern Time on March 11, 2025.

How can I listen to MaxCyte's conference call?

To listen, register online at least a day in advance and access the webcast on their website.

What is MaxCyte's participation in the TD Cowen conference?

MaxCyte will participate in a fireside chat on March 3, 2025, at 10:30 a.m. ET.

Where can I access the archived webcast of the events?

Archived webcasts will be available in the 'Events' section of MaxCyte's investor relations website.

Tags: MXCT Viatris Investor Conferences Healthcare MaxCyte Q4 2024 financial results investor conference cell therapeutics
Last updated: Feb 7, 2025